Basic Materials [ 12/13 ] | Specialty Chemicals [ 101/163 ]
NYSE | Common Stock
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally.
It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments.
The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions.
Its Personal Care segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers.
The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding.
Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone.
It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical.
The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022.
Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 1, 24 | 1.27 Decreased by -11.19% | 1.14 Increased by +11.40% |
| Jan 31, 24 | 0.45 Decreased by -53.61% | 0.19 Increased by +136.84% |
| Nov 8, 23 | 0.41 Decreased by -71.92% | 0.63 Decreased by -34.92% |
| Jul 25, 23 | 1.23 Decreased by -34.92% | 1.27 Decreased by -3.15% |
| May 2, 23 | 1.43 Decreased by -4.67% | 1.50 Decreased by -4.67% |
| Jan 31, 23 | 0.97 Increased by +10.23% | 0.99 Decreased by -2.02% |
| Nov 7, 22 | 1.46 Increased by +19.67% | 1.41 Increased by +3.55% |
| Jul 26, 22 | 1.89 Increased by +54.92% | 1.67 Increased by +13.17% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 23 | 848.00 M Increased by +61.52% | 26.00 M Decreased by -35.00% | Increased by +3.07% Decreased by -59.76% |
| Sep 30, 23 | 518.00 M Decreased by -17.91% | -4.00 M Decreased by -107.02% | Decreased by -0.77% Decreased by -108.55% |
| Jun 30, 23 | 546.00 M Decreased by -15.22% | 50.00 M Decreased by -1.96% | Increased by +9.16% Increased by +15.64% |
| Mar 31, 23 | 603.00 M Decreased by -0.17% | 91.00 M Increased by +139.47% | Increased by +15.09% Increased by +139.87% |
| Dec 31, 22 | 525.00 M Increased by +2.54% | 40.00 M Decreased by -16.67% | Increased by +7.62% Decreased by -18.73% |
| Sep 30, 22 | 631.00 M Increased by +6.77% | 57.00 M Increased by +32.56% | Increased by +9.03% Increased by +24.16% |
| Jun 30, 22 | 644.00 M Increased by +1.10% | 51.00 M Decreased by -36.25% | Increased by +7.92% Decreased by -36.94% |
| Mar 31, 22 | 604.00 M Increased by +1.00% | 38.00 M Decreased by -7.32% | Increased by +6.29% Decreased by -8.24% |